Sign in to view content

Suprachoroidal Delivery of RGX-314 Gene Therapy for Diabetic Retinopathy: Phase II ALTITUDE Study

Charles C Wykoff, MD, PhD, FASRS

Video
Published 2022

Related

What Happens to Diabetic Retinopathy Severity Scores With Less Aggressive Treatment? A Post Hoc Analysis of the RISE and RIDE Open Label Extension Study
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2019
Lower Socioeconomic Status Is Associated With Increased Bevacizumab Use Among Patients Initiating Anti-VEGF Therapy for Diabetic Macular Edema
Judy E. Kim, MD, FASRS
Annual Meeting Talks
2025
National Cohort Study on New Oral Hypoglycemic Agents in Diabetic Retinopathy Progression
Ehsan Rahimy, MD
Annual Meeting Talks
2023

Category: Diabetic Retinopathy

See more